Moreover, serum levels of soluble PD-L1 were shown to predict treatment response and progression-free survival in 81 newly diagnosed MM patients [59] and high soluble PD-L1 levels in bone marrow plasma from 61 MM patients were associated with shorter response after autologous stem cell transplant (ASCT) and shorter overall survival [60]. Here, CD274 is linked to Miyoshi myopathy.